The Recall Desk
CriticalFDA (Devices)·Z-2099-2017·Announced 2017-08-16

Cook Medical Recalls Zenith Alpha Thoracic Endovascular Grafts

Cook Medical is recalling Zenith Alpha Thoracic Endovascular Grafts due to reports of graft thrombosis and occlusion, including one patient death.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The source text explicitly states that one case resulted in patient death, which mandates a severity score of 5 (Critical) according to the rubric.

Plain-English summary

Cook Medical Incorporated is recalling the Zenith Alpha Thoracic Endovascular Graft, a medical device used for the endovascular treatment of patients with isolated lesions of the descending thoracic aorta. The recall covers 4,916 units distributed nationwide.

The recall was initiated following five reports of graft thrombosis or occlusion during global commercial use, each occurring after treatment for BTAI (Bleeding Thoracic Aortic Injury). One of these cases resulted in patient death, and three cases required reintervention.

Patients who have received this device should contact their healthcare provider for guidance on monitoring and potential follow-up care. The recall applies to all lots of the affected catalog numbers.

The recalled product

Product
Zenith Alpha Thoracic Endovascular Graft The Zenith Alpha" Thoracic Endovascular Graft is indicated for the endovascular treatment of patients with isolated lesions of the descending thoracic aorta (not including dissections) having vascular anatomy suitable for endovascular r
Affected units
4,916

Distribution

Distributed nationwide across the United States.